Patents by Inventor Martin Donsbach

Martin Donsbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING INFLAMMATORY DISEASES USING ADENOSINE 2B RECEPTOR ANTAGONISTS
    Publication number: 20140142113
    Abstract: A method of treating inflammatory diseases with Adenosine 2B receptor antagonists in particular with xanthine derived inhibitors. The method involves supplying a therapeutically active amount of the compounds of FIG. 1 and in particular compound 1.
    Type: Application
    Filed: November 11, 2013
    Publication date: May 22, 2014
    Inventors: Michael W. Burnet, Thomas Stohr, Martin Donsbach
  • Method for producing 3,3-diarylpropylamines
    Patent number: 6809225
    Abstract: A novel method is described for producing 3,3-diarylpropylamines by hyroformylation/hydrocarbonylation and then reductive amination using a transition metal catalyst.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: October 26, 2004
    Assignee: Schwarz Pharma AG
    Inventors: Martin Donsbach, Peter Eilbracht, Christian Buss, Andreas Schmidt
  • Method for producing 3,3-diarylpropylamines
    Publication number: 20040034080
    Abstract: The invention relates to a novel method for producing 3,3-diarylpropylamines of formula (I), wherein A represents a substituted or unsubstituted aryl radical, X represents H, OH or OR3 and Y, R1, R2 and R3 have the meanings given in the description, by hydroformylation/hydrocarbonylation and subsequent reductive amination using a transition metal catalyst.
    Type: Application
    Filed: July 14, 2003
    Publication date: February 19, 2004
    Inventors: Martin Donsbach, Peter Eilbracht, Christian Buss, Andreas Schmidt